Skip to main content
Peptide Daily.
Research

Ipamorelin

Selective growth hormone secretagogue with minimal side effects.

Grade

A

Finnrick lab signal

Lowest

$27.50Lowest
Peptide Partners

Trust

92trust
← Back to peptide comparison
Price comparison

Current offers across tracked vendors

Lowest price first, with Finnrick grades in the same row so cost never gets divorced from lab context.

Source: Vendor websitesLast tested Mar 2026
VendorPriceConcentrationGradeUpdatedLink
Peptide Partners$27.505mgAMar 24, 2026Vendor ↗
Polaris Peptides$28.505mgMar 24, 2026Vendor ↗
Verified Peptides$29.995mgMar 24, 2026Vendor ↗
Paradigm Peptide$30.995mgAMar 24, 2026Vendor ↗
Lab data

What the Finnrick results actually show

We highlight current purity and quantity results without implying every vendor or every batch has been tested equally.

Purity distribution

No Finnrick test results are attached to this peptide yet.

Peptide Partners

7 tests · avg lab score 8.9/10

A

Latest Finnrick test Nov 10, 2025

Paradigm Peptide

4 tests · avg lab score 9.1/10

A

Latest Finnrick test Nov 1, 2025

Price history

Historical tracking comes next

The current schema gives us a trustworthy live market snapshot. It does not yet store price snapshots over time, so the chart module stays honest about that gap.

Historical pricing

Tracking starts with snapshots

The current schema stores live prices but not historical snapshots yet, so this page shows current market comparison rather than pretending time-series data exists. Once snapshots are recorded, this module can render 30-, 90-, and 180-day trends honestly.

Research context

Editorial context beyond the price table

The goal is to keep market data inside a broader research and safety frame, not let the price table become the whole story.

Research information only

Peptide Daily is an informational resource only. Peptide research chemicals are not approved for human use by the FDA unless otherwise noted. Nothing on this site constitutes medical advice. Consult a qualified healthcare provider before using any peptide or research chemical.